AI assistant
Oncopeptides Major Shareholding Notification 2022
3091_iss_2022-03-25_7c5eec96-86be-4955-9f17-62f06e894537.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Oncopeptides AB
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
| Instrument |
|---|
| ------------ |
| Instrument | Aktier | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given Data not given |
|
| Voting rights | ||
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 24/03/2022 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 2,261,652 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 2,261,652 | |
| Percentage | ||
| Directly held shares | 3.00385 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 3.00385 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 3.00385 % | 2,261,652 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | 1.97616 % | 1,487,890 |
| Total | 4.98001 % | 3,749,542 |
Group total holdings
Voting rights 3,749,542 Percentage of voting rights 4.98001
Notes (other relevant informations according to law)
Flaggning sker för passerat tröskelvärde beträffande det aggregerade innehavet. Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt avyttrat de aktuella värdepapperna.
Published
25/03/2022 10:00
Contact
Name Joakim Lomell
Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25